Changes in midbrain serotonin transporter availability in atypically depressed subjects after one year of psychotherapy

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 32, Issue 1, 2008, Pages 229-237

  Lehto, Soili M ^a   Tolmunen, Tommi ^a   Joensuu, Mikko ^a   Saarinen, Pirjo I ^a   Valkonen Korhonen, Minna ^a   Vanninen, Ritva ^a   Ahola, Pasi ^a   Tiihonen, Jari ^b   Kuikka, Jyrki ^a   Lehtonen, Johannes ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Atypical depression; Depression; Dopamine transporter; Psychotherapy; Serotonin transporter; SPECT

Indexed keywords

DOPAMINE TRANSPORTER; IODINE 123; NOR 2 BETA CARBOMETHOXY 3 BETA (4 IODOPHENYL)TROPANE I 123; RADIOPHARMACEUTICAL AGENT; SEROTONIN TRANSPORTER; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ATYPICAL DEPRESSION; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; FEMALE; HAMILTON SCALE; HUMAN; MALE; MESENCEPHALON; NEUROIMAGING; OUTPATIENT; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; PSYCHODYNAMICS; PSYCHOTHERAPY; SEROTONINERGIC SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; ANALYSIS OF VARIANCE; COCAINE; CORPUS STRIATUM; DEPRESSION; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; IODINE ISOTOPES; MALE; MESENCEPHALON; PSYCHOTHERAPY; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 38349057730     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2007.08.013     Document Type: Article

References (58)

1. Acton P.D., Kushner S.A., Kung M.P., Mozley P.C., Plossl K., and Kung H.F. Simplified reference region model for the kinetic analysis of [99mTc]TRODAT-1 binding to dopamine transporters in nonhuman primates using single-photon emission tomography. Eur J Nucl Med 26 (1990) 518-526
2. Akiskal H.S., Akiskal K.K., Perugi G., Toni C., Ruffolo G., and Tusini G. Bipolar II and anxious reactive "comorbidity": toward better phenotypic characterization suitable for genotyping. J Affect Disord 96 (2006) 239-247
3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th edn (1994), DSM-IV, Washington, DC
4. Angst J., Gamma A., Sellaro R., Zhang H., and Merikangas K. Toward validation of atypical depression in the community: results of the Zurich Cohort Study. J Affect Disord 72 (2002) 125-138
5. Asberg M., Traskman L., and Thoren P. 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor?. Arch Gen Psychiatry 33 (1976) 1193-1197
6. Asnis G.M., McGinn L.K., and Sanderson W.C. Atypical depression: clinical aspects and noradrenergic function. Am J Psychiatry 152 1 (1995) 31-36
7. 3H]paroxetine binding to serotonin uptake sites in human brain tissue. Brain Res 486 (1989) 261-268
8. Benazzi F. Prevalence and clinical features of atypical depression in depressed outpatients: a 467-case study. Psychiatry Res 93 (1999) 257-262
9. Benazzi F. Can only reserved vegetative symptoms define atypical depression?. Eur Arch Psychiatry Clin Neurosci 252 (2002) 288-293
10. Carroll F.I., Kotian P., Dehghani A., Gray J.L., Kuzemko M.A., Parham K.A., et al. Cocaine and 3 beta-(4'-substituted phenyl)tropane-2 beta-carboxylic acid ester and amide analogues. New high-affinity and selective compounds for the dopamine transporter. J Med Chem 38 (1995) 379-388
11. Caspi A., Sugden K., Moffitt T.E., Taylor A., Craig I.W., Harrington H., et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301 (2003) 386-389
12. Davidson J.R., Miller R.D., Turnbull C.D., and Sullivan J.L. Atypical depression. Arch Gen Psychiatry 39 (1982) 527-534
13. Fava M., and Davidson K.G. Definition and epidemiology of treatment-resistant depression. Psychiatr Clin North Am 19 (1996) 179-200
14. Gold P.W., Goodwin F.K., and Chrousos G.P. Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress. N Engl J Med 319 (1988) 348-353
15. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 23 (1960) 56-62
16. Hamilton M. Hamilton rating scale for depression. Handbook of Psychiatric measures (2000), American Psychiatric Association 526-529
17. Herold N., Uebelhack K., Franke L., Amthauer H., Luedemann L., Bruhn H., et al. Imaging of serotonin transporters and its blockade by citalopram in patients with major depression using a novel SPECT ligand [123I]-ADAM. J Neural Transm 113 (2006) 659-670
18. Hiltunen J., Åkerman K., Kuikka J., Bergström K., Halldin C., Nikula T., et al. Iodine-123 labeled nor-β-CIT as a potential tracer for serotonin transporter imaging in the human brain with single-photon emission tomography. Eur J Nucl Med 25 (1998) 19-23
19. Horwath E., Johnson J., Weissmann M.M., and Hornig C.D. The validity of major depression with atypical features based on a community study. J Affect Disord 26 (1992) 117-126
20. Jarrett R.B., Schaffer M., McIntire D., Witt-Browder A., Kraft D., and Risser R.C. Treatment of atypical depression with cognitive therapy or phenelzine: a double-blind, placebo-controlled trial. Arch Gen Psychiatry 56 (1999) 431-437
21. Jarrett R.B., Kraft D., Schaffer M., Witt-Browder A., Risser R., Atkins D.H., et al. Reducing relapse in depressed outpatients with atypical features: a pilot study. Psychother Psychosom 69 (2000) 232-239
22. Joensuu M., Tolmunen T., Saarinen P.I., Tiihonen J., Kuikka J., Ahola P., et al. Reduced midbrain serotonin transporter availability in drug-naive patients with depression measured by SERT-specific [(123)I] nor-beta-CIT SPECT imaging. Psychiatry Res 154 (2007) 125-131
23. Keller M.B., Lavori P.W., Mueller T.I., Endicott J., Coryell W., Hirschfeld R.M., et al. Time to recovery, chronicity, and levels of psychopathology in major depression. A 5-year prospective follow-up of 431 subjects. Arch Gen Psychiatry 49 (1992) 809-816
24. Kendler K.S., Eaves L.J., Walters E.E., Neale M.C., Heath A.C., and Kessler R.C. The identification and validation of distinct depressive syndromes in a population-based sample of female twins. Arch Gen Psychiatry 5 (1996) 391-399
25. Kuikka J.T., Tenhunen-Eskelinen M., Jurvelin J., and Kiiliäinen H. Physical performance of the Siemens MultiSPECT3 gamma camera. Nucl Med Commun 23 (1993) 798-803
26. Laruelle M., Giddings S.S., Zea-Ponce Y., Charney D.S., Neumeyer J.L., Baldwin R.M., and Innis R.B. Methyl 3 beta-(4-[125I]iodophenyl)tropane-2 beta-carboxylate in vitro binding to dopamine and serotonin transporters under "physiological" conditions. J Neurochem 62 (1994) 978-986
27. 123I]nor-β-CIT in atypical depression. Prog Neuropsychopharmacol Biol Psychiatry 30 (2006) 1251-1255
28. Linden D.E. How psychotherapy changes the brain - the contribution of functional neuroimaging. Mol Psychiatry 11 (2006) 528-538
29. Logan J., Fowler J.S., Volkow N.D., Wang G.J., Ding Y.S., and Alexoff D.L. Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab 16 (1996) 834-840
30. Malison R.T., Price L.H., Berman R., van Dyck C.H., Pelton G.H., Carpenter L., et al. Reduced brain serotonin transporter availability in major depression as measured by (4-iodophenyl) tropane and single photon emission computed tomography. Biol Psychiatry 44 (1998) 1090-1098
31. Mann J.J., Huang Y.Y., Underwood M.D., Kassir S.A., Oppenheim S., Kelly T.M., et al. A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Arch Gen Psychiatry 57 (2000) 729-738
32. Matza L.S., Revicki D.A., Davidson J.R., and Stewart J.W. Depression with atypical features in the National Comorbidity Survey. Arch Gen Psychiatry 60 (2003) 817-826
33. Mercier M.A., Stewart J.W., and Quitkin F.M. A pilot sequential study of cognitive therapy and pharmacotherapy of atypical depression. J Clin Psychiatry 53 (1992) 166-170
34. Meyer J.H., Houle S., Sagrati S., Carella A., Hussey D.F., Ginovart N., et al. Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes. Arch Gen Psychiatry 61 (2004) 1271-1279
35. Meyer J.H., Wilson A.A., Sagrati S., Hussey D., Carella A., Potter W.Z., et al. Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study. Am J Psychiatry 161 (2004) 826-835
36. Meyer J.H., Ginovart N., Boovariwala A., Sagrati S., Hussey D., Garcia A., et al. Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression. Arch Gen Psychiatry 63 (2006) 1209-1216
37. Newberg A.B., Amsterdam J.D., Wintering N., Ploessl K., Swanson R.L., Shults J., and Alavi A. 123I-ADAM binding to serotonin transporters in patients with major depression and healthy controls: a preliminary study. J Nucl Med 46 (2005) 973-977
38. Nierenberg A.A., Alpert J.E., Pava J., Rosenbaum J.F., and Fava M. Course and treatment of atypical depression. J Clin Psychiatry 59 (1998) 5-9
39. Oquendo M.A., Hastings R.S., Huang Y.Y., Simpson N., Ogden R.T., Hu X.Z., et al. Brain serotonin transporter binding in depressed patients with bipolar disorder using positron emission tomography. Arch Gen Psychiatry 64 (2007) 201-208
40. Owens M.J., and Nemeroff C.B. Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clin Chem 40 (1994) 288-295
41. Parker G.B., and Crawford J. A spectrum model for depressive conditions: extrapolation of the atypical depression prototype. J Affect Disord (2007) 10.1016/j.jad.2007.01.022
42. Parker G.B., and Thase M.E. Atypical depression: a valid subtype?. J Clin Psychiatry 68 Suppl 3 (2007) 18-22
43. Pezawas L., Meyer-Lindenberg A., Drabant E.M., Verchinski B.A., Munoz K.E., Kolachana B.S., et al. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat Neurosci 8 (2005) 828-834
44. Praschak-Rieder N., Kennedy J., Wilson A.A., Hussey D., Boovariwala A., Willeit M., et al. Novel 5-HTTLPR allele associates with higher serotonin transporter binding in putamen: A [(11)C] DASB positron emission tomography study. Biol Psychiatry (2007) [Jan 6: (Epub ahead of print)]
45. Quintana J. Platelet serotonin and plasma tryptophan decreases in endogenous depression. clinical, therapeutic, and biological correlations. J Affect Disord 24 (1992) 55-62
46. Quitkin F.M., Stewart J.W., McGrath P.J., Liebowitz M.R., Harrison W.M., Tricamo E., et al. Phenelzine versus imipramine in the treatment of probable atypical depression: defining syndrome boundaries of selective MAOI responders. Am J Psychiatry 145 (1988) 306-311
47. Quitkin F.M. Depression with atypical features: diagnostic validity, prevalence, and treatment. Prim care companion. J Clin Psychiatry 4 (2002) 94-99
48. Roose S.P., Glassman A.H., Attia E., and Woodring S. Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia. Am J Psychiatry 151 (1994) 1735-1739
49. Rudnick G., and Clark J. From synapse to vesicle: the reuptake and storage of biogenic amine neurotransmitters. Biochim Biophys Acta 1144 (1993) 249-263
50. Saarinen P.I., Lehtonen J., Joensuu M., Tolmunen T., Ahola P., Vanninen R., et al. Outcome of psychodynamic psychotherapy: activation of the dream screen and change in the serotonin transporter density. Am J Psychother 59 (2005) 61-73
51. Stewart J.W., McGrath P., Rabkin J., and Quitkin F.M. Atypical depression: a valid clinical entity?. Psychiatr Clin North Am 16 (1993) 479-495
52. Stewart J.W., Garfinkel R., Nunes E.V., Donovan S., and Klein D.F. Atypical features and treatment response in the National Institute of Mental Health Treatment of Depression Collaborative Research Program. J Clin Psychopharmacol 18 (1998) 429-434
53. Talairach J., and Tournoux P. Referentially oriented cerebral MRI anatomy (1993), Thieme, New York
54. Tolmunen T., Joensuu M., Saarinen P., Mussalo H., Ahola P., Vanninen R., et al. Elevated serotonin transporter density in mixed mania: a case-control study. BMC Psychiatry 4 (2004) 27
55. Viinamäki H., Kuikka J., Tiihonen J., and Lehtonen J. Change in monoamine transporter density related to clinical recovery: a case-control study. Nord J Psychiatry 52 (1998) 39-44
56. Vergne D.E., and Nemeroff C.B. The interaction of serotonin transporter gene polymorphisms and early adverse life events on vulnerability for major depression. Curr Psychiatry Rep 8 (2006) 452-457
57. West E.D., and Dally P.J. Effect of iproniazid in depressive syndromes. Br Med J 1 (1959) 1491-1494
58. Williams J.B., Link M.J., Rosenthal N.E., and Terman M. Structured interview guide for the Hamilton depression rating scale. Seasonal Affective Disorders Version (1988), Psychiatric Institute, New York: New York